Gastrointestinal and Hepatic Manifestations of 2019 Novel Coronavirus Disease in a Large Cohort of Infected Patients From New York: Clinical Implications
Kaveh Hajifathalian(NewYork–Presbyterian Hospital), David Cohen, Angela Wong, Arjun Ravishankar, Bryan Ang(Cornell University), Xiaohan Ying(Cornell University), Shawn L. Shah(NewYork–Presbyterian Hospital), Carl V. Crawford, David L. Carr‐Locke(Cornell University), Rachel Niec, Tibor I. Krisko(NewYork–Presbyterian Hospital), Julia Speiser, Qais Dawod(NewYork–Presbyterian Hospital), Robert E. Schwartz(Autonomix Medical (United States)), Daniel Skaf(Cornell University), Aiya Aboubakr, Anthony Choi, Russell Rosenblatt(Cornell University), Mallory Ianelli, Elizabeth A. Rohan, David Wan(Cornell University), SriHari Mahadev(NewYork–Presbyterian Hospital), Anjana Rajan, Sunena Tewani, Yushan Pan, Reem Z. Sharaiha(NewYork–Presbyterian Hospital), Alyson Kaplan(Tufts Medical Center), Amit Mehta(NewYork–Presbyterian Hospital), Evan Sholle, Robert S. Brown(Cornell University), Enad Dawod(Cornell University), Sonal Kumar(NewYork–Presbyterian Hospital), Brett E. Fortune(Montefiore Medical Center)
Cited by 155
Related Papers
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799
A molecular single-cell lung atlas of lethal COVID-19
|Nature|2021|735